Copyright © 2007, European Society of Cardiology
Acute inhibition of Rho-kinase improves cardiac contractile function in streptozotocin-diabetic rats
aDivision of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC Canada
bJames Hogg iCapture Centre for Cardiovascular and Pulmonary Research, Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC Canada
* Corresponding author. Faculty of Pharmaceutical Sciences, University of British Columbia, 2146 East Mall, Vancouver, BC Canada V6T 1Z3. Tel.: +1 604 822 0219; fax: +1 604 822 3035. kmm{at}interchange.ubc.ca
Objective The purpose of the present study was to determine whether increased activation of the RhoA/Rho-kinase (ROCK) pathway occurs in diabetic cardiomyopathy and whether acute inhibition of this pathway improves contractile function of the diabetic heart.
Methods Male Wistar rats were made diabetic with streptozotocin. Twelve to fourteen weeks later, the effects of acute administration of the ROCK inhibitors Y-27632 and H-1152 on cardiac contractile function were measured both in vitro, in isolated working hearts, and in vivo, using echocardiography. Changes in the expression and activity of RhoA, and the effect of ROCK inhibition on changes in the phosphorylation of the downstream target of ROCK, LIM kinase 2, and on actin polymerization in diabetic hearts were also determined.
Results Perfusion of isolated working hearts from diabetic rats with Y-27632 or H-1152 acutely improved left ventricle developed pressure and the rates of contraction and relaxation. Acute administration of H-1152 also significantly improved the percent fraction shortening, an index of left ventricle contractility, in vivo in diabetic rats. The expression and activity of RhoA in cardiomyocytes from diabetic rats were significantly increased, as was the phosphorylation of LIM kinase 2. This was associated with an increase in actin polymerization (the F-actin to G-actin ratio). Both the increase in LIM kinase 2 phosphorylation and actin polymerization were attenuated by ROCK inhibition.
Conclusions These data suggest that activation of the RhoA/ROCK signaling pathway plays a critical role in the development of diabetic cardiomyopathy, and that ROCK is an excellent therapeutic target in the treatment of this condition.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  P. R. Nagareddy, H. Soliman, G. Lin, P. S. Rajput, U. Kumar, J. H. McNeill, and K. M. MacLeod Selective Inhibition of Protein Kinase C {beta}2 Attenuates Inducible Nitric Oxide Synthase-Mediated Cardiovascular Abnormalities in Streptozotocin-Induced Diabetic Rats Diabetes, October 1, 2009; 58(10): 2355 - 2364. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Soliman, G. P. Craig, P. Nagareddy, V. G. Yuen, G. Lin, U. Kumar, J. H. McNeill, and K. M. MacLeod Role of inducible nitric oxide synthase in induction of RhoA expression in hearts from diabetic rats Cardiovasc Res, July 15, 2008; 79(2): 322 - 330. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Yu, D. A. Quinn, H. G. Garg, and C. A. Hales Deficiency of the NHE1 Gene Prevents Hypoxia-induced Pulmonary Hypertension and Vascular Remodeling Am. J. Respir. Crit. Care Med., June 1, 2008; 177(11): 1276 - 1284. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Pemberton Leptin-induced cardiac hypertrophy: RhoAing a lipid raft down a protective p38 MAPK signalling stream? Cardiovasc Res, January 1, 2008; 77(1): 4 - 5. [Full Text] [PDF]
|
|
|
|
|
|
S. L.M. Peters and M. C. Michel The RhoA/Rho kinase pathway in the myocardium Cardiovasc Res, July 1, 2007; 75(1): 3 - 4. [Full Text] [PDF]
|
|